BeStock  
Stocks › Biotechnology › KRYS

Krystal Biotech KRYS

US equityMarket cap rank #1486Biotechnology
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$127.34M+30.2% YoY
Operating profit$71.15M+72.0% YoY
Net profit$63.07M-20.5% YoY
Diluted EPS$2.05-22.9% YoY
Free cash flow$90.25M+137.8% YoY
Operating cash flow$91.25M

Revenue, last 8 quarters

$91.1MDec '24$88.2MMar '25$96.0MJun '25$97.8MSep '25$107.1MDec '25$116.4MMar '26$119.2MJun '26$127.3MSep '26

Net profit, last 8 quarters

$45.5MDec '24$35.7MMar '25$38.3MJun '25$79.4MSep '25$51.4MDec '25$55.9MMar '26$54.8MJun '26$63.1MSep '26

Diluted EPS by quarter

1.52Dec '241.20Mar '251.29Jun '252.66Sep '251.70Dec '251.83Mar '261.79Jun '262.05Sep '26

Free cash flow by quarter

$52.0MDec '24$24.8MMar '25$50.8MJun '25$38.0MSep '25$75.4MDec '25$73.2MMar '26$71.2MJun '26$90.3MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$50.7MFY23$290.5MFY24$389.1MFY25

Profitability & balance sheet

Gross margin94.3%
Operating margin48.4%
Net margin47.9%
Return on equity17.5%
Return on assets15.9%
Return on invested capital15.3%
Current ratio7.89
Liabilities / assets9.5%
Cash & investments$911.85M
Total debt$6.77M
Net cash (debt)$905.08M
Free cash flow / sales66.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $127.34M $119.22M $116.36M $389.13M $107.11M
Total Operating Revenue $127.34M $119.22M $116.36M $389.13M $107.11M
Cost of Revenue $7.56M $6.44M $6.32M $23.05M $6.59M
Gross Profit $119.79M $112.79M $110.03M $366.08M $100.51M
Operating Expense $48.64M $54.37M $56.35M $204.79M $56.24M
Selling and Admin Expenses $33.75M $39.85M $41.01M $146.74M $41.45M
Research & Development $14.89M $14.52M $15.33M $58.05M $14.79M
Operating Profit $71.15M $58.42M $53.69M $161.30M $44.27M
Net Non-Operating Interest Income (Expense) $9.00M $7.66M $7.75M $28.18M $6.86M
Non-Operating Interest Income $9.00M $7.66M – $28.18M $6.86M
Pretax Profit $80.15M $66.08M $61.44M $189.47M $51.13M
Tax $17.08M $11.31M $5.51M -$15.36M -$269,000.00
Net Profit $63.07M $54.77M $55.93M $204.83M $51.40M
Profit from Continuing Operations $63.07M $54.77M $55.93M $204.83M $51.40M
Net Income to Parent Company $63.07M $54.77M $55.93M $204.83M $51.40M
Net Income to Common Stockholders $63.07M $54.77M $55.93M $204.83M $51.40M
Basic EPS $2.13 $1.85 $1.91 $7.08 $1.77
Diluted EPS $2.05 $1.79 $1.83 $6.84 $1.70
Total Other Finance Costs – – -$7.75M – –
Special Income (Charges) – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.59B $1.50B $1.40B $1.33B $1.33B
Total Current Assets $1.12B $1.06B $1.02B $1.02B $1.02B
Cash and Cash Equivalents & Short-Term Investments $911.85M $845.63M $823.41M $827.79M $827.79M
-Cash and Cash Equivalents $462.84M $427.74M $501.31M $496.30M $496.30M
-Short Term Investments $449.01M $417.89M $322.09M $331.49M $331.49M
Receivables $133.12M $138.66M $127.02M $127.43M $127.43M
-Accounts Receivable $133.12M $138.66M $127.02M $127.43M $127.43M
Prepaid Assets $8.54M $15.31M $10.64M $14.01M $14.01M
Inventory $50.79M $45.56M $42.65M $40.48M $40.48M
Other Current Assets $17.47M $14.49M $16.03M $14.91M $14.91M
Total Non-Current Assets $464.29M $441.00M $377.23M $309.19M $309.19M
Net PPE $158.90M $160.60M $160.62M $158.02M $158.02M
-Gross PPE $197.97M $196.97M $194.39M $189.30M $189.30M
-Accumulated Depreciation -$39.07M -$36.37M -$33.77M -$31.28M -$31.28M
Investments and Advances $282.30M $257.29M $193.49M $128.07M $128.07M
-Available for Sale Securities $282.30M $257.29M $193.49M $128.07M $128.07M
Non-Current Deferred Assets $22.82M $22.82M $22.82M $22.82M $22.82M
Other Non-Current Assets $269,000.00 $284,000.00 $300,000.00 $287,000.00 $287,000.00
Total Liabilities $150.47M $141.52M $120.24M $114.23M $114.23M
Total Current Liabilities $142.14M $127.40M $107.80M $102.94M $102.94M
Payables $23.60M $21.35M $17.20M $14.16M $14.16M
-Accounts Payable $6.73M $6.54M $4.09M $3.24M $3.24M
-Total Tax Payable $16.87M $14.81M $13.11M $10.92M $10.92M
Current Accrued Expenses $112.40M $100.81M $85.63M $83.44M $83.44M
Short-Term Debt and Capital Lease Obligation $1.82M $1.81M $1.80M $1.77M $1.77M
-Current Capital Lease Obligation $1.82M $1.81M $1.80M $1.77M $1.77M
Other Current Liabilities $4.33M $3.43M $3.18M $3.58M $3.58M
Total Non-Current Liabilities $8.33M $14.13M $12.44M $11.29M $11.29M
Long Term Debt and Capital Lease Obligation $6.77M $7.05M $7.31M $7.57M $7.57M
-Long Term Capital Lease Obligation $6.77M $7.05M $7.31M $7.57M $7.57M
Other Non-Current Liabilities $1.56M $7.08M $5.12M $3.72M $3.72M
Total Equity $1.44B $1.36B $1.28B $1.22B $1.22B
Stockholders' Equity $1.44B $1.36B $1.28B $1.22B $1.22B
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.25B $1.23B $1.20B $1.19B $1.19B
Retained Earnings $197.93M $134.86M $80.10M $24.16M $24.16M
Gains/Losses Not Affecting Retained Earnings -$9.24M -$4.34M -$1.62M $1.14M $1.14M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $91.25M $74.79M $80.38M $200.87M $77.51M
Net cash flow from continuing operations $91.25M $74.79M $80.38M $200.87M $77.51M
Net Income from Continuing Operations $63.07M $54.77M $55.93M $204.83M $51.40M
Gain/Loss from Continuing Operations -$475,000.00 -$748,000.00 -$529,000.00 -$5.95M -$404,000.00
Depreciation & Depletion & Amortization $1.69M $1.57M $1.73M $6.55M $1.76M
Other Non-Cash Items -$490,000.00 $174,000.00 $136,000.00 $684,000.00 $289,000.00
Change in Working Capital $14.29M $5.62M $10.08M -$36.42M $9.50M
-Change in Receivables $5.43M -$11.97M $58,000.00 -$22.12M $2.49M
-Change in Inventory -$2.00M -$958,000.00 -$243,000.00 -$6.29M -$1.06M
-Change in Prepaid Assets $2.99M -$4.86M $1.67M -$14.66M -$245,000.00
-Change in Payables and Accrued Expense $8.35M $21.64M $7.40M $4.95M $7.91M
-Change in Other Current Liabilities -$470,000.00 $1.77M $1.21M $1.70M $397,000.00
Net cash flow from investing -$57.98M -$161.58M -$63.58M -$58.42M $11.16M
Net Cash Flow from Continuing Investing Activities -$57.98M -$161.58M -$63.58M -$58.42M $11.16M
Net PPE Purchase and Sale -$996,000.00 -$3.57M -$7.15M -$11.95M -$2.14M
Net Investment Purchase and Sale -$56.99M -$158.02M -$56.44M -$46.90M $13.30M
Financing Cash Flow $3.41M $15.05M -$10.46M $8.71M $15.67M
Net Cash Flow from Continuing Financing Activities $3.41M $15.05M -$10.46M $8.71M $15.67M
Proceeds from Stock Option Exercised $3.42M $15.16M $6.50M $22.66M $15.69M
Net Other Financing Charges -$11,000.00 -$108,000.00 -$16.96M -$13.96M -$23,000.00
Ending Cash Balance $462.84M $427.74M $501.31M $496.30M $496.30M
Net Change in Cash $36.68M -$71.74M $6.34M $151.15M $104.34M
Beginning Cash Balance $427.74M $501.31M $496.30M $344.87M $392.60M
Effect of Exchange Rate Changes -$1.58M -$1.83M -$1.33M $286,000.00 -$637,000.00
Free Cash Flow $90.25M $71.22M $73.23M $188.91M $75.37M
Deferred Tax – – – -$22.85M $1.84M
Net Other Investing Changes – – – $435,000.00 $0.00
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on KRYS.

Sign in to join the discussion.

Scroll to Top